ARVN

Arvinas Inc (ARVN)

US
$ 00%

Price Chart

Key Statistics

Market Cap
$ 535.95M
P/E Ratio
0.00
Revenue (TTM)
$ 372.8M
Volume
0
52W High
$ 29.61
52W Low
$ 5.90
Dividend Yield
0.00%
Beta
2.23

Technicals

50-Day MA
7.4576
200-Day MA
13.1325
52 Week High
29.6106
52 Week Low
5.9

About ARVN

Arvinas, Inc., a clinical-stage biotechnology company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins.

Employees
430
Headquarters
New Haven, CT
CEO
Dr. John G. Houston Ph.D.

Latest News

Advanced Charts

Access professional-grade trading charts and technical analysis tools

Top Gainers

Symbol/Name
LTP
% Chg

Top Losers

Symbol/Name
LTP
% Chg